SCHEMBL30673306

SCHEMBL30673306

N#Cc1cc(Br)cc(F)c1O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 6/20 0.39
ESR2 Q92731 6/20 0.39
MEN1 O00255 1/20 0.39
TTR P02766 1/20 0.39
ALB P02768 1/20 0.39
KMT2A Q03164 1/20 0.39
CYP11B1 P15538 1/20 0.37
CYP11B2 P19099 1/20 0.37
TRPV4 Q9HBA0 2/20 0.36
CYP3A4 P08684 1/20 0.36
TSHR P16473 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
GABRA1 P14867 2/20 0.34
GABRB1 P18505 2/20 0.34
GPR35 Q9HC97 2/20 0.33
GABRA2 P47869 1/20 0.32
GABRB2 P47870 1/20 0.32
MAOA P21397 1/20 0.32
MAOB P27338 1/20 0.32
KHK P50053 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL505061 1.00 ESR1 (0.39) ESR1ESR2MEN1TTRALB
SCHEMBL21192755 0.83 ALDH1A1 (0.31) ESR1ESR2GPR35
SCHEMBL1423613 0.78 CYP3A4 (0.56) MEN1TTRALBKMT2ACYP3A4
SCHEMBL29560065 0.78 TRPV4 (0.39) ESR1ESR2CYP11B1CYP11B2TRPV4
SCHEMBL29786557 0.78 ERN1 (0.42) ESR1ESR2CYP11B1CYP11B2TRPV4
SCHEMBL4254090 0.78 ERN1 (0.42) ESR1ESR2CYP11B1CYP11B2TRPV4
SCHEMBL504867 0.78 TRPV4 (0.39) ESR1ESR2CYP11B1CYP11B2TRPV4
SCHEMBL13029 0.77 CYP3A4 (0.50) ESR1ESR2CYP3A4TSHRTDP1
SCHEMBL25190108 0.75 CYP11B1 (0.37) ESR1ESR2CYP11B1CYP11B2TRPV4
SCHEMBL22119985 0.75 KHK (0.39) ESR1ESR2CYP11B1CYP11B2TRPV4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4518974-A1 IMIDAZO(1,2-A)PYRIDINE DERIVATIVES AS RIPK2 INHIBITORS Interline Therapeutics, Inc. (US) 2025-03-12 EP disclosed
WO-2024254537-A1 METHODS OF TREATING INFLAMMATORY DISEASES INTERLINE THERAPEUTICS, INC. (US) 2024-12-12 WO disclosed
WO-2023239941-A1 IMIDAZO(1,2-A)PYRIDINE DERIVATIVES AS RIPK2 INHIBITORS INTERLINE THERAPEUTICS INC. (US) 2023-12-14 WO disclosed